StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
MBRX

Moleculin Biotech, Inc.

MBRX Nasdaq Pharmaceutical Preparations EDGAR ↗
$0.43
-0.59 -58.33%

Key statistics

from XBRL data in SEC filings
Market cap
$2.27M
Revenue (TTM)
$0.00
Net income (TTM)
-$40.5M
EPS (TTM)
$-16.16
P/E ratio
Dividend yield
Free cash flow
Cash
$10.3M
Total assets
$23.4M
Gross margin
52-week range
$0.16 – $18.25

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Entered a material agreement Aug 3, 2026 8-K Regulation FD disclosure Jul 31, 2026 8-K Regulation FD disclosure Jun 30, 2026 8-K Regulation FD disclosure Jun 30, 2026 8-K Regulation FD disclosure Jun 5, 2026 8-K Regulation FD disclosure May 29, 2026 8-K Regulation FD disclosure May 26, 2026 8-K Regulation FD disclosure May 22, 2026 8-K Results of operations (earnings release) May 15, 2026 10-Q Quarter ended 2026-03-31 May 14, 2026 8-K Regulation FD disclosure May 13, 2026 8-K Regulation FD disclosure May 12, 2026 8-K Regulation FD disclosure May 8, 2026 8-K Regulation FD disclosure Apr 23, 2026 8-K Shareholder vote results Apr 15, 2026 10-K/A Fiscal year ended 2025-12-31 Apr 14, 2026 8-K Regulation FD disclosure Mar 23, 2026 8-K Regulation FD disclosure Mar 19, 2026 8-K Results of operations (earnings release) Mar 19, 2026 10-K Fiscal year ended 2025-12-31 Mar 18, 2026 8-K Entered a material agreement; Unregistered sale of equity Feb 20, 2026 8-K Regulation FD disclosure Feb 18, 2026 8-K Regulation FD disclosure Feb 18, 2026 8-K Regulation FD disclosure Feb 17, 2026 8-K Shareholder vote results Feb 5, 2026 8-K Regulation FD disclosure Jan 20, 2026 8-K Regulation FD disclosure Jan 13, 2026 8-K Regulation FD disclosure Jan 12, 2026 8-K Other events Jan 7, 2026 8-K Entered a material agreement; Other events Dec 22, 2025 8-K Regulation FD disclosure Dec 17, 2025 8-K Other events Dec 16, 2025 8-K Entered a material agreement; Unregistered sale of equity Dec 10, 2025 8-K Regulation FD disclosure Dec 9, 2025 8-K Regulation FD disclosure Dec 8, 2025 8-K Modified rights of security holders; Amended charter or bylaws; Other events Nov 28, 2025 8-K Regulation FD disclosure Nov 24, 2025 8-K Delisting notice or listing-rule failure Nov 21, 2025 10-Q Quarter ended 2025-09-30 Nov 13, 2025 8-K Regulation FD disclosure Nov 13, 2025